CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancerChi–Che Hsieh(National Health Research Institutes), Che‐Hung Shen(Kaohsiung Medical University)British Journal of CancerAugust 23, 202210.1038/s41416-022-01946-9Cited by 33SaveCiteExport RISWatch citationsRelated PapersAMPK-Dependent Degradation of TXNIP upon Energy Stress Leads to Enhanced Glucose Uptake via GLUT1|Molecular Cell|2013|672